Clinical Trial Update: Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intradermal injections of Newfill versus Eutrophill for facial lipoatrophy in HIV-infected patients has completed, assessing safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Lipodystrophy Syndrome

Drugs mentioned

• Eutrophill
• Newfill

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV-Associated Lipodystrophy Syndrome | Phase 3 | Status: COMPLETED